Chemistry Reference
In-Depth Information
evidence for the involvement of zinc and copper in Alzheimer's disease.
Eur. J. Clin. Invest.
,
29
, 569-570; (d) Atwood, C.S., Huang, X., Moir, R.D.
et al.
(1999) Role of free radicals and
metal ions in the pathogenesis of Alzheimer's disease.
Met. Ions Biol. Sys.
,
36
, 309-364;
(e) Atwood, C.S., Scarpa, R.C., Huang, X.
et al.
(2000) Charaterization of copper interaction
with Alzheimer amyloid b peptides: Identification of an attomolar-affinity copper binding site
on amyloid b1-42.
J. Neurochem.
,
75
, 1219-1233; (f) Mirura, T., Suzuki, K., Kohata, N., and
Takeuchi, H. (2000) Metal binding modes of Alzheimer's amyloid b-peptide in insoluble
aggregates and soluble complexes.
Biochemistry
,
39
, 7024-7031; (g) Morgan, D.M., Dong, J.,
Jacob, J.
et al.
(2002) Metal switch for amyloid formation: Insight into the structure of the
nucleus.
J. Am. Chem. Soc.
,
124
, 12644-12645; (h) Dong, J., Atwood, C.S., Anderson, V.E.
et al.
(2003) Metal binding and oxidation of amyloid-b within isolated senile plaque cores:
Raman microscopic evidence.
Biochemistry
,
42
, 2768-2773; (i)Kowalik-Jankowska, T., Ruta,
M., Wisniewska, K., and Łankiewicz, L. (2003) Coordination abilities of the 1-16 and 1-28
fragments of b-amyloid peptide toward copper(II) ions: a combined potentiometric and
spectroscopic study.
J. Inorg. Biochem.
,
95
270-282.
189. (a) Markesbery, W.R. (1997) Oxidative stress hypeothesis in Alzheimer's disease.
Free Rad.
Biol. Med.
,
23
, 134-147; (b) Sayre, L.M., Zagorski, M.G., Surewicz, W.K.
et al.
(1997) Mech-
anisms of neurotoxicity associated with amyloid b deposition and the role of free radicals
in the pathogenesis of Alzheimer's disease: A critical appraisal.
Chem.Res.Toxicol.
,
10
,
518-526; (c) Bondy, S.C., Guo-Ross, S.X., and Truong, A.T. (1998) Promotion of transition
metal-induced reactive oxygen species formation by b-amyloid.
Brain Res
,
799
, 91-96; (d)
Behl, C. (1999) Alzheimer's disease and oxidative stress: Implications for novel therapeutic
approach.
Prog. Neurobiol.
,
323
, 301-323; (e) Huang, Y., Atwood, C.S., Hartshorn, M.A.
et al.
(1999) The Ab peptide of Alzheimer's disease directly produces hydrogen peroxide
through metal ion reduction.
Biochemistry
,
38
, 7609-7616; (f) Huang, Y., Cuajungco, M.P.,
Atwood, C.S.
et al.
(1999) Alzheimer's Ab interaction with Cu(II) induces neurotoxicity, rad-
icalization, metal reduction, and cell-free hydrogen peroxide formation.
J. Biol. Chem.
,
274
,
37111-37116; (g) Yatin, S.M., Varadarajan, S., Link, C.D., and Butterfield, D.A. (1999)
In
vitro
and
in vivo
oxidative stress associated with Alzheimer's amyloid b-peptide (1-42).
Neu-
robiol. Aging
,
20
, 325-330; (h) Pratico, D. and Delanty, N. (2000) Oxidative injury in diseases
of the central nervous system: focus on Alzheimer's disease.
Physiol. Med.
,
109
, 577-585; (i)
Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D.A. (2000) Review: Alzheimer's
amyloid b-peptide-associated free radical oxidative stress and neurotoxicity.
J. Struct. Biol.
,
130
, 184-208; (j) Miranda, S., Opazo, C., Larrondo, L.F.
et al.
(2000) The role of oxidative
stress in the toxicity indiced by amyloid b-peptide in Alzheimer's disease.
Progr. Neurobiol.
,
62
, 633-648; (k) Rottkamp, K.A., Raina, A.K., Zhu, X.
et al.
(2001) Redox-active iron medi-
ates amyloid-b toxicity.
Free Radical Biol. Med.
,
30
, 447-450; (l) Butterfield, D.A., Drake, J.,
Pocemich, C., and Castegna, A. (2001) Evidence of oxidative damage in Alzheimer's disease
brain: central role for amyloid b-peptide.
Trends Mol. Med.
,
7
, 548-554; (m) Nelson, T.J. and
Alkon, D.L. (2005) Oxidation of Cholesterol by Amyloid Precursor Protein and b-Amyloid
Peptide.
J. Biol. Chem
,
280
7377-7387; (n) References in above papers.
190. (a) Tabaton, M. and Piccini, A. (2005) Role of water-soluble amyloid-beta in the pathogenesis
of Alzheimer's disease.
Int. J. Exp. Pathol.
,
86
, 139-145. (the most recent review); (b) Gen-
tile, M.T., Vecchione, C., Maffei, A.
et al.
(2004) Mechanisms of soluble beta-amyloid impair-
ment of endothelial function.
J. Biol. Chem.
,
279
, 48135-48142; (c) Smith, C.C.T. Stanyer, L.,
and Betteridge, D.J. (2004) Soluble beta-amyloid (A beta) 40 causes attenuation or potentia-
tion of noradrenaline-induced vasoconstriction in rats depending upon the concentration
employed.
Neurosci. Lett.
,
367
, 129-132; (d) Klyubin, I., Walsh, D.M., Cullen, W.K.
et al.
(2004) Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation
in
vivo
.
Eur. J. Neurosci.
,
19
, 2839-2846; (e) Zerbinatti, C.V., Wozniak, D.F., Cirrito, J.
et al.
Search WWH ::
Custom Search